Clinical Trials Logo

Joint Diseases clinical trials

View clinical trials related to Joint Diseases.

Filter by:

NCT ID: NCT00899717 Completed - Clinical trials for Temporomandibular Joint Disorders

Occlusal Adjustment as Treatment for Chronic Orofacial Pain

Start date: May 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether occlusal adjustment by selective grinding and/or occlusal addition is an effective treatment of chronic temporomandibular joint disorders.

NCT ID: NCT00860873 Completed - Osteoarthrosis Clinical Trials

Effectiveness of Glucosamine + Chondroitin in Osteoarthrosis

Start date: October 2009
Phase: Phase 3
Study type: Interventional

This study objective is to check the non-inferiority of the 2 formulations produced by EMS when compared with the same substances and pharmaceuticals forms of the product Condroflex (Zodiac), by promoting the relief of osteoarthrosis symptoms such as pain, stiffness and functional capacity that will be periodically measured by using the "Visual Analog Scale" of pain (VAS) and the questionnaire of Lequesne.

NCT ID: NCT00859976 Completed - Arthropathy of Hip Clinical Trials

Study Comparing BoneMaster Hydroxyapatite Coating With Plasma-sprayed Hydroxyapatite Coating on Acetabular Cups

Start date: March 2009
Phase: N/A
Study type: Interventional

The randomised controlled trial will be carried out on patients that require a total hip replacement (THR) to reduce pain and restore their function. One way of fixing the hip joint to the bone is by coating the implant to encourage the body to grow bone onto the replacement hip. This study is aiming to find out whether the new (Bonemaster) coating allows increased bony growth onto the cup when compared to the usual (plasma-sprayed) coating. This may reduce the incidence of early failures due to poor bony attachment, which is a well known complication for early failure of total hip replacements. The study will compare two different types of coating (BoneMaster and Plasma-sprayed) on the cup of the replacement hip. Density of the bone immediately surrounding the cup will be observed to see if there are differences between the two groups. The density of bone will be measured using standard x−ray assessment and in a smaller sample of 14 patients, using a special scan called Dual Energy X−ray Absorptiometry (DEXA Scan). Functional comparisons will be assessed through clinical scores.

NCT ID: NCT00819481 Completed - Clinical trials for Rheumatoid Arthritis

Post-Market Study of the 3DKnee™ System

Start date: February 2009
Phase:
Study type: Observational

The purpose of this study is to evaluate the use and efficacy of the 3DKnee™ System for total knee replacement surgery.

NCT ID: NCT00815243 Completed - Trauma Clinical Trials

Telemedicine Consultation in Trauma and Orthopedic

TeleTO
Start date: September 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether telemedicine consultations (lead by standard scheme)allows to increase quality of anatomical and functional outcomes and improve clinical work-flow at patients with acute bone and joint trauma, hip pathology and congenital orthopedics abnormalities.

NCT ID: NCT00784277 Completed - Osteoarthritis Clinical Trials

A Study to Compare the Frequency of Constipation Symptoms With Tapentadol Immediate Release (IR) Treatment Versus Oxycodone IR Treatment in Patients With End-stage Joint Disease

Start date: October 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare bowel function/constipation that occurs during tapentadol treatment with that occuring during oxycodone treatment, as measured by the frequency of spontaneous bowel movements per week. The frequency of spontaneous bowel movements will be determined from a Bowel Function Patient Diary completed by the enrolled sujbects.

NCT ID: NCT00782197 Completed - Joint Disease Clinical Trials

Autologous Plasma Rich in Growth Factors (PRGF) Treating the Symptomatic Knee OA

Start date: January 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of PRGF infiltrations in the treatment of knee osteoarthritis.

NCT ID: NCT00696059 Completed - Clinical trials for Rheumatoid Arthritis

Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?

HURRAH
Start date: August 2004
Phase: Phase 4
Study type: Interventional

Studies on tumor necrosis factor alpha antagonist (anti-TNF) therapy in rheumatoid arthritis (RA) patients have found that erosive damage may "heal" in some RA patients treated with anti-TNF. Repeated examinations of adalimumab (Humira) treated RA patients, using computed tomography (CT), magnetic resonance imaging (MRI), ultrasonography (US) and radiography will allow detailed assessment of the extent of bone repair/healing during adalimumab (Humira) therapy.

NCT ID: NCT00669123 Completed - Osteoarthritis Clinical Trials

Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis

Start date: n/a
Phase: Phase 4
Study type: Interventional

The purpouse of this study is to determine the efficacy and safety of chondroitin sulphate conventional treatment in patients with both knee osteoarthritis and plaque psoriasis.

NCT ID: NCT00651430 Completed - Clinical trials for Osteoarthrosis, Balance Control, Voluntary Movement Control

Physical Functioning Following Total Hip Arthroplasty

Start date: March 2008
Phase: N/A
Study type: Observational

Adults suffer from Osteoarthrosis of hip joint that willing to participate in the study will be tested with well-established measuring techniques of Balance control using force plate before 3 month and 6 month after Total Knee Arthroplasty (THA) in the movement and Rehabilitation Laboratory at BGU. An automated algorithm will be used to extract standardized stabilogram-diffusion parameters from each of the COP data sets collected during quiet standing. These parameters include diffusion coefficients, critical displacement, critical time and scaling exponents for both lateral and anterior-posterior sway directions (Collins & De Luca, 1993). Each of the Times (before 3 month and 6 month after the THA) in two task conditions (eyes closed and eyes close conditions). Participants will be required to stand on the platform 10 times for 30 s For each trial, they will be instructed to sway as little as possible. In addition step execution test and Late life function and disability questionnaires will be also examined.